Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akero Therapeutics

53.84
+0.18000.34%
Post-market: 53.890.0500+0.09%19:52 EDT
Volume:1.58M
Turnover:84.69M
Market Cap:4.31B
PE:-14.24
High:53.87
Open:53.67
Low:53.63
Close:53.66
52wk High:58.40
52wk Low:21.34
Shares:79.99M
Float Shares:67.77M
Volume Ratio:0.33
T/O Rate:2.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7801
EPS(LYR):-3.7544
ROE:-31.14%
ROA:-20.36%
PB:4.20
PE(LYR):-14.34

Loading ...

Oct 09, 2025

Major Issues Report

Form 8-K - Current report
Oct 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 29, 2025

Major Issues Report

Form 8-K - Current report
Sep 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2025

Major Issues Report

Form 8-K - Current report
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
May 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2025

Major Issues Report

Form 8-K - Current report
May 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2025

Major Issues Report

Form 8-K - Current report